Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: α Therapy with 223Ra-Dichloride-Reference-Cited by-同舟云学术

Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: α Therapy with 223Ra-Dichloride

Published:2013-12-16 Issue:2 Volume:55 Page:268-274
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Pandit-Taskar Neeta,Larson Steven M.,Carrasquillo Jorge A.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference39 articles.

1. Bone remodeling, normal and abnormal: a biological basis for the understanding of cancer-related bone disease and its treatment;Parfitt;Can J Oncol.,1995

2. Physiology and pathophysiology of bone remodeling;Raisz;Clin Chem.,1999

3. Biology of bone metastases;Theriault;Cancer Control,2012

4. Cancer Pain Relief: With a Guide to Opioid Availability. 2nd ed. Geneva, Switzerland: World Health Organization; 1996:36–37.

5. WHO cancer pain relief programme;Stjernswärd;Cancer Surv.,1988

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results;International Journal of Molecular Sciences;2024-01-04

2. Feasible Strategy for Large-Scale Production of ²²⁴Ra as a Promising α-Emitting Therapy Radionuclide;Industrial & Engineering Chemistry Research;2023-08-25

3. Kemik Metastazlarının Tedavisinde Radyofarmasötiklerin Rolü;Fabad Journal of Pharmaceutical Sciences;2023-05-02

4. Laser isotope separation of 223Ra;Scientific Reports;2023-04-28

5. Radionuclide-based theranostics — a promising strategy for lung cancer;European Journal of Nuclear Medicine and Molecular Imaging;2023-03-16